Research Christmas 2020: The Citadel The shared risk of diabetes between dog and cat owners and their pets: register based cohort study Rachel Ann Delicano, Ulf Hammar, Agneta Egenvall, et al BMJ 2020;371:m4337 doi: https://doi.org/10.1136/bmj.m4337 (Published 10 December 2020) Abstract Objective To investigate whether dog and cat owners and their pets share a risk of developing diabetes. Design Cohort study. Setting Register based longi...

Original Investigation December 8, 2020 Effect of Co-trimoxazole (Trimethoprim-Sulfamethoxazole) vs Placebo on Death, Lung Transplant, or Hospital Admission in Patients With Moderate and Severe Idiopathic Pulmonary Fibrosis: The EME-TIPAC Randomized Clinical Trial Andrew M. Wilson, Allan B. Clark, Tony Cahn, et al JAMA. 2020;324(22):2282-2291. doi:10.1001/jama.2020.22960 Abstract Importance Idiopathic pulmonary fibrosis (IPF) has a poor pr...

Viewpoint December 17, 2020 COVID-19 as the Leading Cause of Death in the United States Steven H. Woolf, Derek A. Chapman, Jong Hyung Lee JAMA. Published online December 17, 2020. doi:10.1001/jama.2020.24865 The current exponential increase in coronavirus disease 2019 (COVID-19) is reaching a calamitous scale in the United States, potentially overwhelming the health care system and causing substantial loss of life. The news media dutifully repor...

Research Letter October 30, 2020 Peripheral Oxygen Saturation in Older Persons Wearing Nonmedical Face Masks in Community Settings Noel C. Chan, Karen Li; Jack Hirsh JAMA. 2020;324(22):2323-2324. doi:10.1001/jama.2020.21905 Based on the evidence that nonmedical face masks prevent the spread of severe acute respiratory syndrome coronavirus 2,1,2 many governments are mandating the wearing of masks in the community. However...

JAMA Insights November 23, 2020 Diagnosis, Management, and Pathophysiology of Arterial and Venous Thrombosis in COVID-19 Gregory Piazza, David A. Morrow JAMA. 2020;324(24):2548-2549. doi:10.1001/jama.2020.23422 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with arterial and venous thrombotic complications. In a US registry of patients with coronavirus disease 2019 (COVID-19), thrombotic complications occurred in 2.6%...

Editorials Remdesivir: a pendulum in a pandemic lan S Schwartz, Emily L Heil, Erin K McCreary BMJ 2020; 371: m4560 doi: https://doi.org/10.1136/bmj.m4560 (Published 24 November 2020) New guidance challenges remdesivir use for patients with covid-19 Covid-19 has claimed over a million lives globally and devastated healthcare systems, economies, and societal welfare. Determining effective, safe, and scalable prevention and treatment measures is the top priori...

Research Letter December 22/29, 2020 Uptake and Accuracy of the Diagnosis Code for COVID-19 Among US Hospitalizations Sameer S. Kadri, Jake Gundrum, Sarah Warner, et al JAMA. 2020;324(24):2553-2554. doi:10.1001/jama.2020.20323 Administrative claims may provide an understanding of the clinical and economic burden of novel coronavirus disease 2019 (COVID-19). However, their limited sensitivity in identifying conditions, such as sepsis,1 sugge...

Original Investigation November 24, 2020E20-260 200-101 Effect of Nebulized Magnesium vs Placebo Added to Albuterol on Hospitalization Among Children With Refractory Acute Asthma Treated in the Emergency Department: A Randomized Clinical Trial Suzanne Schuh, Judy Sweeney, Maggie Rumantir, et al JAMA  2020;324(20):2038-2047. doi:10.1001/jama.2020.19839 Abstract Importance While intravenous magnesium decreases h...

Feature Christmas 2020: The Citadel Harms and the Xmas factor Robin E Ferner, Jeffrey K Aronson BMJ 2020; 371: m4067 (Published 16 December 2020) doi: https://doi.org/10.1136/bmj.m4067 The Christmas season is associated with preventable harms from cards, tree decorations, and presents, as well as overeating and overdrinking. Given the balance of benefits and harms, Christmas may not be cost effective. We hope you’re well, that you’ve posted the last of...

FeatureHPE6-A44 HPE6-A43 Covid-19: What now for remdesivir? Jeremy Hsu BMJ 2020; 371: m4457 doi: https://doi.org/10.1136/bmj.m4457 (Published 20 November 2020) The spectre of past pandemics looms large over remdesivir, one of the first drug treatments for covid-19. With a WHO trial finding little benefit, Jeremy Hsu asks if the expensive drug is just Tamiflu redux? It’s a cautionary tale worth remembering amid the coronavi...